4/A
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-20-045921
SVP, General Counsel and Sec sold 13,374 shares at $20.00 ($267,480)
- SVP, General Counsel and Sec acquired 13,374 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sandercock Colin SVP, General Counsel and Sec | 2020-08-05 | Option exercise | +13,374 | $7.50 | $100,305 | 30,499 | D: show line 1 in the form |
| Sandercock Colin SVP, General Counsel and Sec | 2020-08-05 | Sale | −13,374 | $20.00 | $267,480 | 17,125 | D: show line 2 in the form |
| Open-market sales · 13,374 sh · avg $20.00 · $267,480 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Sandercock Colin SVP, General Counsel and Sec | 2020-08-05 | Option exercise · Stock Option (right to buy) | −13,374 | 130,000 | D: show line 3 in the form |
Loading xslF345X03/doc4a.xml…